← Back
Data updated: Jul 17, 2026
PURDUE FREDERICK
Pharma Pharmaceuticals
PURDUE FREDERICK is a pharmaceutical company with 1 FDA-approved products.
1974
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
PURDUE FREDERICK's Key Drugs
PURDUE FREDERICK's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
PURDUE FREDERICK's Recent FDA Approvals
New NDA/BLA approvals for PURDUE FREDERICK over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
PURDUE FREDERICK's Therapeutic Areas
Disease areas where PURDUE FREDERICK has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
PURDUE FREDERICK Pipeline Snapshot
Active clinical trials for PURDUE FREDERICK across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1974-04-02
- Latest
- 1978-08-09
- Applications
- 1